RecallDepth
Class III Terminated

Lovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-316-00) and b)1000-count bottles (NDC 68001-316-08), Rx Only, Manufactured by: Lupin Limited, Goa 403 722 INDIA For BluePoint Laboratories.

This recall has been terminated (originally issued August 14, 2019).

Company
American Health Packaging
Recall Initiated
February 19, 2019
Posted
August 14, 2019
Recall Number
D-1584-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
14,360 bottles
Firm Location
Columbus, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.

Distribution

Nationwide within the USA and Puerto Rico

Lot / Code Info

Lot #: a) G702705 and b) G702706, Exp. 3/31/2020

More recalls by American Health Packaging

View all recalls by this company →

Other recent Class III Drug recalls